Skyscape Web Viewer : DrDrugs®: Drug Guide for Physicians : Pharmacologic Index

View All
pancreatics diazoxide insulin (mixtures) insulin degludec insulin glargine/lixisenatide insulin lispro insulin regular glucagon insulin aspart insulin glargine insulin glulisine insulin nph (isophane insulin suspension)
parathyroid hormones teriparatide abaloparatide
penicillinase resistant penicillins dicloxacillin oxacillin nafcillin
penicillins penicillin v penicillin g aqueous pivmecillinam
peripherally acting antiadrenergics alfuzosin prazosin doxazosin terazosin
pharmacoenhancers
phenothiazines fluphenazine prochlorperazine thioridazine chlorpromazine perphenazine promethazine trifluoperazine
phosphate binders aluminum hydroxide lanthanum sucroferric oxyhydroxide ferric citrate sevelamer tenapanor
phosphate supplements
phosphodiesterase inhibitors
phosphodiesterase type 4 inhibitors crisaborole apremilast
phosphodiesterase type 5 inhibitors sildenafil vardenafil avanafil tadalafil
photosensitizers aminolevulinic acid porfimer
piperazine derivatives
piperidines
plasminogen activators tenecteplase alteplase thrombolytic agents
plasminogen inactivators
platelet aggregation inhibitors cangrelor clopidogrel cilostazol ticagrelor
platelet-derived growth factor receptor α blockers avapritinib ripretinib
platelet derived growth factors
podophyllotoxin derivatives etoposide etoposide phosphate
polymerase inhibitors ledipasvir/sofosbuvir sofosbuvir
polypeptides
potassium channel blockers dalfampridine amifampridine
potassium sparing diuretics
progestins elagolix/estradiol/norethindrone medroxyprogesterone progesterone estradiol/progesterone megestrol relugolix/estradiol/norethindrone
programmed death-1 inhibitors cemiplimab nivolumab dostarlimab pembrolizumab
programmed death ligand 1 pd l1 inhibitors atezolizumab durvalumab avelumab
proprotein convertase subtilisin kexin type-9 pcsk-9 inhibitors alirocumab evolocumab
prostacyclin receptor agonists